<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药合作投融资联盟 | wechat-feeds</title><link>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</link><description>医药行业</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 02 Jun 2021 07:53:42 +0800</pubDate><image><url>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</url><title>医药合作投融资联盟 | wechat-feeds</title><link>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>3500万美元B轮融资，加速减肥手术器械商业化</title><link>https://mp.weixin.qq.com/s/uUGIPT8WC6XervhGx2HQIg</link><description></description><content:encoded><![CDATA[3500万美元B轮融资，加速减肥手术器械商业化]]></content:encoded><pubDate>Tue, 01 Jun 2021 21:01:29 +0800</pubDate></item><item><title>3.38亿美元！再鼎医药引进一款KRAS抑制剂adagrasib</title><link>https://mp.weixin.qq.com/s/aFB3eWKzzcQj09P9tfpOLQ</link><description></description><content:encoded><![CDATA[3.38亿美元！再鼎医药引进一款KRAS抑制剂adagrasib]]></content:encoded><pubDate>Tue, 01 Jun 2021 21:01:29 +0800</pubDate></item><item><title>华东医药2800万美元引进一款GLP-1/GIP双靶点激动剂</title><link>https://mp.weixin.qq.com/s/60l0UEfjjCpcrbYItQU5SA</link><description></description><content:encoded><![CDATA[华东医药2800万美元引进一款GLP-1/GIP双靶点激动剂]]></content:encoded><pubDate>Tue, 01 Jun 2021 21:01:29 +0800</pubDate></item><item><title>12.5亿美元！安进宣布引进合作开发一款3期临床OX40单抗</title><link>https://mp.weixin.qq.com/s/GHQ8F-Hd6PnOJe-pLOBaaQ</link><description></description><content:encoded><![CDATA[12.5亿美元！安进宣布引进合作开发一款3期临床OX40单抗]]></content:encoded><pubDate>Tue, 01 Jun 2021 21:01:29 +0800</pubDate></item><item><title>【免费参会】中国AI新药合作大会</title><link>https://mp.weixin.qq.com/s/ZLo2NF051hJRHrwQpXd-cA</link><description></description><content:encoded><![CDATA[【免费参会】中国AI新药合作大会]]></content:encoded><pubDate>Tue, 01 Jun 2021 21:01:29 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/tbN0U2XO5AwX_HW1YijQLQ</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Tue, 01 Jun 2021 21:01:29 +0800</pubDate></item><item><title>重磅！葆元医药和信达生物宣布达成1.89亿美元独家许可协议</title><link>https://mp.weixin.qq.com/s/ALt0TMOhkkY35CMlCAmZgA</link><description></description><content:encoded><![CDATA[重磅！葆元医药和信达生物宣布达成1.89亿美元独家许可协议]]></content:encoded><pubDate>Tue, 01 Jun 2021 21:01:29 +0800</pubDate></item><item><title>估值超10亿美元！乐普旗下心泰科技完成近亿美元融资</title><link>https://mp.weixin.qq.com/s/bPI1D_5CweGYKF7-4h1vQg</link><description></description><content:encoded><![CDATA[估值超10亿美元！乐普旗下心泰科技完成近亿美元融资]]></content:encoded><pubDate>Tue, 01 Jun 2021 06:32:26 +0800</pubDate></item><item><title>创响生物完成1亿美元C轮融资</title><link>https://mp.weixin.qq.com/s/o2n8dF1VFucvUNh35UgBQA</link><description></description><content:encoded><![CDATA[创响生物完成1亿美元C轮融资]]></content:encoded><pubDate>Tue, 01 Jun 2021 06:32:26 +0800</pubDate></item><item><title>创新药研发企业博骥源医药宣布完成pre-A轮融资！</title><link>https://mp.weixin.qq.com/s/xa5GF4qY_KeN_7mhJebAzg</link><description></description><content:encoded><![CDATA[创新药研发企业博骥源医药宣布完成pre-A轮融资！]]></content:encoded><pubDate>Tue, 01 Jun 2021 06:32:26 +0800</pubDate></item><item><title>【免费参会】中国AI新药合作大会</title><link>https://mp.weixin.qq.com/s/5ivPkCyrDdZ5fi1m-40s2Q</link><description></description><content:encoded><![CDATA[【免费参会】中国AI新药合作大会]]></content:encoded><pubDate>Tue, 01 Jun 2021 06:32:26 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/Jwxt0Wb4Av1NWeWcmyRSrg</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Tue, 01 Jun 2021 06:32:26 +0800</pubDate></item><item><title>Frazier Healthcare Partners完成超额认购的14 亿美元成长并购基金募资</title><link>https://mp.weixin.qq.com/s/8yUKEtXUXdGSpak8ADpivQ</link><description></description><content:encoded><![CDATA[Frazier Healthcare Partners完成超额认购的14 亿美元成长并购基金募资]]></content:encoded><pubDate>Mon, 31 May 2021 09:43:17 +0800</pubDate></item><item><title>ADC平台Ambrx提交IPO申请，拟募资1亿美元，多家知名机构背书</title><link>https://mp.weixin.qq.com/s/LiNpA44hyP0Y4NETsvhlUA</link><description></description><content:encoded><![CDATA[ADC平台Ambrx提交IPO申请，拟募资1亿美元，多家知名机构背书]]></content:encoded><pubDate>Mon, 31 May 2021 09:43:17 +0800</pubDate></item><item><title>【免费参会】中国AI新药合作大会</title><link>https://mp.weixin.qq.com/s/HQ9jOrPt-h7hk1Qculq0nw</link><description></description><content:encoded><![CDATA[【免费参会】中国AI新药合作大会]]></content:encoded><pubDate>Mon, 31 May 2021 09:43:17 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/EsuiNFqEl6Wg7AFfMHxPiQ</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Mon, 31 May 2021 09:43:17 +0800</pubDate></item><item><title>新锐|RNA新药miRecule Inc.完成570万美元种子轮融资</title><link>https://mp.weixin.qq.com/s/2bBPPQN8puxuYblPNgDlvQ</link><description></description><content:encoded><![CDATA[新锐|RNA新药miRecule Inc.完成570万美元种子轮融资]]></content:encoded><pubDate>Fri, 28 May 2021 09:26:33 +0800</pubDate></item><item><title>新锐|种子轮融资950万美元，开发年龄相关疾病新药</title><link>https://mp.weixin.qq.com/s/NOKZq_OVU8M-NdO_1YWd1w</link><description></description><content:encoded><![CDATA[新锐|种子轮融资950万美元，开发年龄相关疾病新药]]></content:encoded><pubDate>Fri, 28 May 2021 09:26:33 +0800</pubDate></item><item><title>Pulmocide完成9200万美元C轮融资，用于吸入疗法注册临床试验</title><link>https://mp.weixin.qq.com/s/qE50t1SOkLIxwTX5PdbMvQ</link><description></description><content:encoded><![CDATA[Pulmocide完成9200万美元C轮融资，用于吸入疗法注册临床试验]]></content:encoded><pubDate>Fri, 28 May 2021 09:26:33 +0800</pubDate></item><item><title>GenapSys宣布完成7000万美元D轮融资，用于下一代测序平台</title><link>https://mp.weixin.qq.com/s/MNfdBBoUhdBD0g7cATEU6Q</link><description></description><content:encoded><![CDATA[GenapSys宣布完成7000万美元D轮融资，用于下一代测序平台]]></content:encoded><pubDate>Fri, 28 May 2021 09:26:33 +0800</pubDate></item></channel></rss>